Literature DB >> 17032412

Zinc is a negative regulator of hepatitis C virus RNA replication.

Kazuhisa Yuasa1, Atsushi Naganuma, Ken Sato, Masanori Ikeda, Nobuyuki Kato, Hitoshi Takagi, Masatomo Mori.   

Abstract

BACKGROUND/AIMS: Hepatitis C virus (HCV) infection is a significant global public health problem. In clinical studies, zinc has been closely related to the pathogenesis of chronic hepatitis C. However, the role of zinc in both viral replication and the expression of viral proteins remains unclear. We aimed to clarify the effect of zinc on the replication of HCV in vitro.
METHODS: We incubated subgenomic HCV replicon cells (sO) and genome-length HCV RNA-replicating cells (O) treated with several chemicals including trace elements. Total RNAs were collected and subjected to real-time reverse-transcriptase polymerase chain reaction in order to examine the level of HCV RNA replication, and Western blotting was performed to confirm the expression of viral proteins.
RESULTS: Iron salts and interferon-alpha suppressed HCV RNA replication and protein expression in both sO and O cells. Zinc salts effectively reduced the viral replication in the genome-length HCV RNA replication system but not in the subgenomic HCV replicon system.
CONCLUSIONS: We demonstrated that zinc may play an important role as a negative regulator of HCV replication in genome-length HCV RNA-replicating cells. Zinc supplementation thus appears to offer a novel approach to the development of future strategies for the treatment of intractable chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17032412     DOI: 10.1111/j.1478-3231.2006.01352.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  22 in total

1.  Evaluation of Zinc Plasma Level in Iranian Cirrhotic Patients due to Hepatitis B and Hepatitis C.

Authors:  Mohammad Abbasi Nazari; Sahar Hasani Malayeri; Mohammad Amin Pourhoseingholi; Seyed Reza Mohebi; Mohammad Reza Zali
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

Review 2.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

Review 3.  Oxidative stress modulation in hepatitis C virus infected cells.

Authors:  Sonia A Lozano-Sepulveda; Owen L Bryan-Marrugo; Carlos Cordova-Fletes; Maria C Gutierrez-Ruiz; Ana M Rivas-Estilla
Journal:  World J Hepatol       Date:  2015-12-18

4.  Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase?

Authors:  Zhaowen Zhu; Anne T Wilson; Bruce A Luxon; Kyle E Brown; M Meleah Mathahs; Sarmistha Bandyopadhyay; Anton P McCaffrey; Warren N Schmidt
Journal:  Hepatology       Date:  2010-12       Impact factor: 17.425

Review 5.  Can zinc enhance response interferon therapy for patients with HCV-related liver disease?

Authors:  Toru Ishikawa
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

Review 6.  Antioxidants as therapeutic agents for liver disease.

Authors:  Ashwani K Singal; Sarat C Jampana; Steven A Weinman
Journal:  Liver Int       Date:  2011-07-29       Impact factor: 5.828

7.  Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study.

Authors:  Mohammad Abbasinazari; Seyed Moayed Alavian; Bita Behnava; Mansour Asgharinia; Shima Salimi; Maryam Keshvari; Leala Mehrnoush; Pegah Karim
Journal:  J Clin Diagn Res       Date:  2014-12-05

8.  Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression.

Authors:  Julio A Gutierrez; Krysten A Jones; Roxana Flores; Akul Singhania; Christopher H Woelk; Robert T Schooley; David L Wyles
Journal:  J Virol Antivir Res       Date:  2014-10-06

9.  Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure-Activity Relationships.

Authors:  Katherine Hu; Zhaowen Zhu; Meleah M Mathahs; Huy Tran; Jerry Bommer; Charles A Testa; Warren N Schmidt
Journal:  Drug Des Devel Ther       Date:  2020-02-24       Impact factor: 4.162

10.  Heme and HO-1 Inhibition of HCV, HBV, and HIV.

Authors:  Warren N Schmidt; M Meleah Mathahs; Zhaowen Zhu
Journal:  Front Pharmacol       Date:  2012-10-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.